Literature DB >> 3899444

The fibrinolytic system of the vascular wall.

L A Erickson, R R Schleef, T Ny, D J Loskutoff.   

Abstract

The vascular endothelium produces both PAs and a PAI. The activities of these components in the circulation must be regulated precisely to ensure that normal vascular homeostasis is not compromised. The blood contains a number of molecules that may function in this way by either promoting or inhibiting the synthesis, release and/or activity of the PAs and PAI. It is clear that the regulation of this system is considerably more complex than previously thought. For example, the initiation of fibrin dissolution is influenced by a number of additional factors including fibrin itself, pro-activators, PAI, platelet components (including the PAI), and possibly by APC generated at the endothelial cell surface. Despite the many recent advances discussed above, little is known about the temporal control of the events leading to plasminogen activation during thrombus formation and dissolution. Obviously, such information must be obtained before more effective treatments of abnormal vascular fibrinolytic activity can be developed. In this chapter, we have described a number of reagents and assays that should aid in the quantification of the PAs and the PAI in plasma. Eventual utilization of these assays in a clinical setting may be valuable for the diagnosis and subsequent treatment of abnormalities of the vascular fibrinolytic system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899444

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


  14 in total

1.  Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.

Authors:  M P Bevilacqua; R R Schleef; M A Gimbrone; D J Loskutoff
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.

Authors:  D Ginsburg; R Zeheb; A Y Yang; U M Rafferty; P A Andreasen; L Nielsen; K Dano; R V Lebo; T D Gelehrter
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

3.  Binding of tissue plasminogen activator to cultured human endothelial cells.

Authors:  K A Hajjar; N M Hamel; P C Harpel; R L Nachman
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.

Authors:  T Kooistra; E D Sprengers; V W van Hinsbergh
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

5.  Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages.

Authors:  H Feldmann; H Bugany; F Mahner; H D Klenk; D Drenckhahn; H J Schnittler
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 6.  Thrombosis and atherosclerosis: regulatory role of interactions among blood components and endothelium.

Authors:  R E Scharf; L A Harker
Journal:  Blut       Date:  1987-09

7.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells.

Authors:  T D Gelehrter; R Sznycer-Laszuk
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

8.  The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

Authors:  B A Konkle; D Ginsburg
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

9.  Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.

Authors:  R R Schleef; D L Higgins; E Pillemer; L J Levitt
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

10.  Tissue plasminogen activator, plasminogen activator inhibitor, and other parameters of fibrinolysis in the early stages of taurocholate acute pancreatitis in rats.

Authors:  G Rydzewska; S Kosidlo; A Gabryelewicz; A Rydzewski
Journal:  Int J Pancreatol       Date:  1992-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.